Products
News
Resources
Contact
Language
简体中文
繁體中文
English
日本語
한국어
Tiếng Việt
Overview
Latest
Regional
Industry
Featured
Multimedia
Other Languages
Public Company News
All
APAC
Global
All
APAC
Global
All
APAC
Global
All
APAC
Global
{{toptitleLeft}}
{{toptitleRight}}
{{selectTitle}}
{{toptitleLeft}}
{{index}}
{{select_list_per.name}}
Time
{{showName}}
{{weixin_name}}
X
{{listname}}
Loading
Network Errors Please Retry
{{storydata.story.headline}}
{{storydata.story.date_time}}
{{storydata.story.click_num}}
loading
The End
Network Errors Please Retry
loading
Network Errors Please Retry
{{storydata.headline}}
{{storydata.create_time}}
{{storydata.headline}}
{{storydata.create_time}}
loading
The End
Network Errors Please Retry
loading
Network Errors Please Retry
{{storydata.story.headline}}
{{storydata.story.date_time}}
{{storydata.story.click_num}}
{{storydata.story.headline}}
{{storydata.story.date_time}}
{{storydata.story.click_num}}
loading
The End
Network Errors Please Retry
loading
Network Errors Please Retry
{{storydata.story.headline}}
{{storydata.story.date_time}}
{{storydata.story.click_num}}
{{theme.pcom_theme_name}}
{{storydata.story.headline}}
{{storydata.story.date_time}}
{{storydata.story.click_num}}
{{theme.pcom_theme_name}}
loading
The End
Network Errors Please Retry
SHL Medical and MoonLake Immunotherapeutics collaborate to develop sonelokimab autoinjector
2023-05-03 22:43
EDAN Announces Integration with PointClickCare for Better Senior Primary Care
2023-05-03 21:56
Lantern Pharma Selects REPROCELL USA to Provide Support for the Phase 2 Harmonic™ Clinical Trial
2023-05-03 21:00
Skyline Therapeutics to Present at the ASGCT 26th Annual Meeting
2023-05-03 12:00
Chula Researchers Develop Rapid MTB Strip Test for Tuberculosis
2023-05-03 11:34
Merck Signs MoU with Ministry of Trade, Industry & Energy and Daejeon City for New Asia Pacific BioProcessing Production Center in South Korea
2023-05-03 10:00
Completion of Enrollment in Cohorts C and G of China Phase II Clinical Study of Osemitamab (TST001) in Combination with CAPOX with or without Nivolumab as First-line Treatment of Gastric/Gastro-esophageal Junction Cancer Patients
2023-05-03 08:00
Topline Results from Two-Year Primary Efficacy Endpoint in Pivotal Phase 3 DUPLEX Study of Sparsentan in Focal Segmental Glomerulosclerosis
2023-05-03 00:22
Cellenkos Announces First Patient Dosed with CK0803 Cell Therapy for Treatment of Amyotrophic Lateral Sclerosis
2023-05-03 00:07
China Jo-Jo Drugstores Receives Hangzhou Municipal People's Government Quality Management Excellence Award
2023-05-02 20:30
Ascletis Announces ASC40, a First-in-Class, Once-Daily Oral FASN Inhibitor, Achieved Endpoints in Phase II Clinical Trial for Acne
2023-05-02 17:30
First Patients in Canada Imaged with Illuccix®: Now Commercially Available Nationwide
2023-05-02 05:00
I-MAB Filed 2022 Annual Report on Form 20-F
2023-05-01 20:00
Concept Medical received IDE approval to investigate safety and efficacy of its MagicTouch Sirolimus Coated Balloon Catheter for the treatment of small coronary artery disease
2023-05-01 18:30
ZIRCON Phase III Kidney Cancer Imaging Study Presented at AUA: New Data Confirms Efficacy in Masses 2cm or Smaller
2023-05-01 08:58
OBiO and CHINAGENE reached a strategic agreement of commercial manufacturing services for gene therapy products
2023-04-29 23:20
IMG-004 demonstrated extended half-life and durable pharmacodynamic characteristics in a Phase 1 study
2023-04-28 17:00
WuXi Biologics Releases 2022 ESG Report Detailing Its Continued Commitment to Sustainability
2023-04-28 14:43
Brii Bio Publishes 2022 Environmental, Social and Governance Report
2023-04-28 09:00
Daewoong Pharmaceutical announces a Global License Agreement for DWP213388, a new drug candidate for autoimmune disease with Vitalli Bio
2023-04-28 08:58
1
108
109
110
111
112
414